DK1112362T3 - Genforandring i genet for G$g(b)3-underenheden i det menneskelige G-protein - Google Patents
Genforandring i genet for G$g(b)3-underenheden i det menneskelige G-proteinInfo
- Publication number
- DK1112362T3 DK1112362T3 DK99947277T DK99947277T DK1112362T3 DK 1112362 T3 DK1112362 T3 DK 1112362T3 DK 99947277 T DK99947277 T DK 99947277T DK 99947277 T DK99947277 T DK 99947277T DK 1112362 T3 DK1112362 T3 DK 1112362T3
- Authority
- DK
- Denmark
- Prior art keywords
- protein
- subunit
- human
- gene change
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4722—G-proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19841299A DE19841299A1 (de) | 1998-09-10 | 1998-09-10 | Genveränderung im Gen für die Gß3-Untereinheit des humanen G-Proteins |
DE19904825 | 1999-02-05 | ||
DE19912049 | 1999-03-18 | ||
DE19914229 | 1999-03-29 | ||
DE19919989 | 1999-04-30 | ||
DE19923539 | 1999-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1112362T3 true DK1112362T3 (da) | 2006-06-19 |
Family
ID=27545102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99947277T DK1112362T3 (da) | 1998-09-10 | 1999-09-06 | Genforandring i genet for G$g(b)3-underenheden i det menneskelige G-protein |
Country Status (9)
Country | Link |
---|---|
US (1) | US6924100B2 (da) |
EP (1) | EP1112362B1 (da) |
JP (1) | JP2002525051A (da) |
AT (1) | ATE317436T1 (da) |
AU (1) | AU6079999A (da) |
CA (1) | CA2342966C (da) |
DE (1) | DE59913114D1 (da) |
DK (1) | DK1112362T3 (da) |
WO (1) | WO2000015785A2 (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19619362A1 (de) * | 1996-05-14 | 1997-11-20 | Basf Ag | Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen |
US20030129616A1 (en) * | 2000-02-03 | 2003-07-10 | Winfried Siffert | Use of a mutation in the gene for the beta3-subunit of human g-protein |
JP4140329B2 (ja) * | 2002-09-25 | 2008-08-27 | 財団法人名古屋産業科学研究所 | 高血圧のリスク診断方法 |
WO2005031341A2 (en) * | 2003-09-29 | 2005-04-07 | Pfizer Health Ab | Methods for predicting development of insulin resistance |
US7608458B2 (en) * | 2004-02-05 | 2009-10-27 | Medtronic, Inc. | Identifying patients at risk for life threatening arrhythmias |
CA2554836A1 (en) * | 2004-02-05 | 2005-08-25 | Medtronic, Inc. | Methods and apparatus for identifying patients at risk for life threatening arrhythmias |
US20050287574A1 (en) * | 2004-06-23 | 2005-12-29 | Medtronic, Inc. | Genetic diagnostic method for SCD risk stratification |
US8335652B2 (en) * | 2004-06-23 | 2012-12-18 | Yougene Corp. | Self-improving identification method |
US8027791B2 (en) * | 2004-06-23 | 2011-09-27 | Medtronic, Inc. | Self-improving classification system |
EP2010169A4 (en) * | 2006-04-10 | 2010-09-08 | Nitromed Inc | ASSESSMENT OF GENETIC RISK IN CARDIAC ERRORS: IMPACT OF THE GENETIC VARIATION OF THE POLYMORPHISM OF A G-PROTEIN BETA-3 SUB-UNIT |
US20110143956A1 (en) * | 2007-11-14 | 2011-06-16 | Medtronic, Inc. | Diagnostic Kits and Methods for SCD or SCA Therapy Selection |
EP2229588A4 (en) * | 2007-11-14 | 2011-05-25 | Medtronic Inc | DIAGNOSTIC KITS FOR CHOOSING THERAPY IN CASE OF SUDDEN DEATH BY CARDIAC ARREST (SCD) OR CARDIAC ARREST (SCA) |
EP2430184A2 (en) * | 2009-05-12 | 2012-03-21 | Medtronic, Inc. | Sca risk stratification by predicting patient response to anti-arrhythmics |
EP2463384A3 (en) | 2010-12-07 | 2013-03-13 | Medtronic, Inc. | Diagnostic kits, genetic markers and methods for SCD or SCA therapy selection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5766851A (en) * | 1995-05-19 | 1998-06-16 | The Johns Hopkins University School Of Medicine | Susceptibility gene for obesity and type II diabetes mellitus |
DE19619362A1 (de) * | 1996-05-14 | 1997-11-20 | Basf Ag | Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen |
DE19637518A1 (de) * | 1996-09-13 | 1998-04-09 | Winfried Siffert | PTX-sensitive G-Proteine, ihre Herstellung und Verwendung |
-
1999
- 1999-09-06 CA CA2342966A patent/CA2342966C/en not_active Expired - Fee Related
- 1999-09-06 WO PCT/EP1999/006534 patent/WO2000015785A2/de active IP Right Grant
- 1999-09-06 DK DK99947277T patent/DK1112362T3/da active
- 1999-09-06 AU AU60799/99A patent/AU6079999A/en not_active Abandoned
- 1999-09-06 JP JP2000570312A patent/JP2002525051A/ja active Pending
- 1999-09-06 DE DE59913114T patent/DE59913114D1/de not_active Expired - Lifetime
- 1999-09-06 EP EP99947277A patent/EP1112362B1/de not_active Expired - Lifetime
- 1999-09-06 AT AT99947277T patent/ATE317436T1/de not_active IP Right Cessation
-
2001
- 2001-03-12 US US09/803,653 patent/US6924100B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20020086297A1 (en) | 2002-07-04 |
CA2342966A1 (en) | 2000-03-23 |
DE59913114D1 (de) | 2006-04-20 |
CA2342966C (en) | 2011-05-03 |
ATE317436T1 (de) | 2006-02-15 |
EP1112362B1 (de) | 2006-02-08 |
WO2000015785A3 (de) | 2000-11-09 |
AU6079999A (en) | 2000-04-03 |
US6924100B2 (en) | 2005-08-02 |
JP2002525051A (ja) | 2002-08-13 |
EP1112362A2 (de) | 2001-07-04 |
WO2000015785A2 (de) | 2000-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1112362T3 (da) | Genforandring i genet for G$g(b)3-underenheden i det menneskelige G-protein | |
CY1123971T1 (el) | Επισημασμενα νουκλεοτιδια | |
DK1562983T3 (da) | Flere varianter af meningokok-protein NMB1870 | |
ATE300613T1 (de) | Menschliche, für zyklische nukleotide spezifische phosphodiesterase | |
HRP20090245T1 (en) | Pyy agonists and uses thereof | |
DK0667910T3 (da) | En Bacillus-promoter, afledt fra en variant af en alpha-amylase-promoter fra Bacillus licheniformis | |
FR2704860B1 (fr) | Sequences de nucleotides du locus cryiiia pour le controle de l'expression de sequences d'adn dans un hote cellulaire. | |
DK1104243T3 (da) | Herbicide midler til tolerante eller resistente majskulturer | |
RS50364B (sr) | Modifikovani faktor viii | |
RS49990B (sr) | Dnk sekvence vezane za kukuruzni transformant pv-zmgt 32 (nk 603) i preparati i metode za njegovu detekciju | |
HUP0103601A2 (hu) | Hízósejtek degranulációját gátló hibrid protein és alkalmazása | |
AR053931A2 (es) | Secuencia de adn que codifica una proteina de a. thaliana que posee actividad de delta -5,7-esterol, delta-7-reductasa, proteina delta-7red | |
DE60138264D1 (de) | Nasenspange | |
CY1106978T1 (el) | Ενζυμα φωσφοδιεστερασης | |
EP1209228A3 (en) | Environmental stress responsive promoter | |
NZ508439A (en) | Novel endometriosis-associated gene | |
EP1064296A4 (en) | THERMOSTABLE DNA POLYMERASE FROM THERMOANAEROBACTER THERMOHYDROSULFURICUS | |
ATE346153T1 (de) | Endogene retrovirale sequenzen, verwandten mit auto-immune krankheiten oder mit schwangerschaftsstörungen | |
ATE348158T1 (de) | Neuartiges collectin | |
TR199802300T2 (xx) | �nsan G proteini �3 alt-birimindeki bir gendeki genetik d�n���m�n hastal�klar�n te�hisi i�in kullan�lmas�. | |
DE60126602D1 (de) | Neue collectine | |
ATE335091T1 (de) | Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen | |
EA199900893A1 (ru) | Бактериальные плазмиды | |
CY1106337T1 (el) | Μια ακολουθια dna του ενζυμου φωσφολιπαση α1 απο ciliate tetrahymena και η χρησιμοποιηση του | |
DE60140552D1 (de) | Transglutaminase genprodukte |